Jim Simons started to build up the position in Processa Pharmaceuticals in Q2 2022 and continued to invest until Q4 2023. Since then they sold 116 shares. The investor sold all their shares in Q1 2024 and doesn't own any shares in Processa Pharmaceuticals anymore.